BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20660573)

  • 1. Mitochondrial DNA mutation in normal margins and tumors of recurrent head and neck squamous cell carcinoma patients.
    Dasgupta S; Koch R; Westra WH; Califano JA; Ha PK; Sidransky D; Koch WM
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1205-11. PubMed ID: 20660573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
    Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mitochondrial mutation discovery using ultra-deep sequencing of the mitochondrial genome reveals spatial tumor heterogeneity in head and neck squamous cell carcinoma.
    Schubert AD; Channah Broner E; Agrawal N; London N; Pearson A; Gupta A; Wali N; Seiwert TY; Wheelan S; Lingen M; Macleod K; Allen H; Chatterjee A; Vassiliki S; Gaykalova D; Hoque MO; Sidransky D; Suresh K; Izumchenko E
    Cancer Lett; 2020 Feb; 471():49-60. PubMed ID: 31830557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in the D-loop of mitochondrial DNA in head and neck squamous cell carcinoma.
    Liu SA; Jiang RS; Wang WY; Lin JC
    Head Neck; 2015 Jun; 37(6):878-83. PubMed ID: 24976238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between mitochondrial DNA instability, mitochondrial DNA large deletions, and nuclear microsatellite instability in head and neck squamous cell carcinomas.
    Poetsch M; Petersmann A; Lignitz E; Kleist B
    Diagn Mol Pathol; 2004 Mar; 13(1):26-32. PubMed ID: 15163006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.
    Ganci F; Sacconi A; Bossel Ben-Moshe N; Manciocco V; Sperduti I; Strigari L; Covello R; Benevolo M; Pescarmona E; Domany E; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
    Ann Oncol; 2013 Dec; 24(12):3082-8. PubMed ID: 24107801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of p53 functional activity in tumor cells and histologically normal mucosa from patients with head and neck squamous cell carcinoma.
    Van der Vorst S; Dekairelle AF; Weynand B; Hamoir M; Gala JL
    Head Neck; 2012 Nov; 34(11):1542-50. PubMed ID: 22109999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.
    Challen C; Brown H; Cai C; Betts G; Paterson I; Sloan P; West C; Birch-Machin M; Robinson M
    Br J Cancer; 2011 Apr; 104(8):1319-24. PubMed ID: 21427725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
    Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
    J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
    Hedberg ML; Goh G; Chiosea SI; Bauman JE; Freilino ML; Zeng Y; Wang L; Diergaarde BB; Gooding WE; Lui VW; Herbst RS; Lifton RP; Grandis JR
    J Clin Invest; 2016 Jan; 126(1):169-80. PubMed ID: 26619122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
    N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
    Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mutations in the PYRIN-containing NLR genes (NLRP) in Head and Neck Squamous Cell Carcinoma.
    Lei Y; Lui VW; Grandis JR; Egloff AM
    PLoS One; 2014; 9(1):e85619. PubMed ID: 24465623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
    Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
    Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.
    Kloss-Brandstätter A; Weissensteiner H; Erhart G; Schäfer G; Forer L; Schönherr S; Pacher D; Seifarth C; Stöckl A; Fendt L; Sottsas I; Klocker H; Huck CW; Rasse M; Kronenberg F; Kloss FR
    PLoS One; 2015; 10(8):e0135643. PubMed ID: 26262956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck.
    Zhou S; Kachhap S; Sun W; Wu G; Chuang A; Poeta L; Grumbine L; Mithani SK; Chatterjee A; Koch W; Westra WH; Maitra A; Glazer C; Carducci M; Sidransky D; McFate T; Verma A; Califano JA
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7540-5. PubMed ID: 17456604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA mutations in pancreatic cancer.
    Kassauei K; Habbe N; Mullendore ME; Karikari CA; Maitra A; Feldmann G
    Int J Gastrointest Cancer; 2006; 37(2-3):57-64. PubMed ID: 17827523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.